Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference

LIVONIA, Mich., June 01, 2017 (GLOBE NEWSWIRE) — Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and NASH, today announced that management will provide a corporate update at LD Micro Invitational, taking place June 6-7 in Los Angeles, California, and at the Jefferies 2017 Global Healthcare Conference, taking place June 6-9, 2017, in New York City.